Study shows how to make (and destroy) a metastatic cancer cell

by CU Anschutz Medical CampusColorado study shows that inhibiting the lysosomal stage of autophagy (and not necessarily the action of the autophagosome) may kill metastatic cancer cells. Credit:

Updated on: May 31,2024

Study shows how to make (and destroy) a metastatic cancer cell

by CU Anschutz Medical CampusColorado study shows that inhibiting the lysosomal stage of autophagy (and not necessarily the action of the autophagosome) may kill metastatic cancer cells. Credit:

Updated on:May 31,2024

'Double life' of key immune protein reveals new strategies for treating cancer and autoimmune diseases

by NYU Langone HealthCredit: CC0 Public DomainInsights into the workings of an immune cell surface receptor, called PD-1, reveal how treatments that restrict its action can potentially be strengt

Updated on: March 20,2024

'Double life' of key immune protein reveals new strategies for treating cancer and autoimmune diseases

by NYU Langone HealthCredit: CC0 Public DomainInsights into the workings of an immune cell surface receptor, called PD-1, reveal how treatments that restrict its action can potentially be strengt

Updated on:March 20,2024

Three doses of COVID-19 mRNA vaccine associated with better outcomes for patients with cancer

byDana-Farber Cancer InstituteForest plot showing results of the multivariable logistic regression analysis following IPTW for the primary endpoint of 30-day mortality among patients with cancer

Updated on: January 03,2024

Three doses of COVID-19 mRNA vaccine associated with better outcomes for patients with cancer

byDana-Farber Cancer InstituteForest plot showing results of the multivariable logistic regression analysis following IPTW for the primary endpoint of 30-day mortality among patients with cancer

Updated on:January 03,2024

New drugs are improving survival times for patients with aggressive type of blood cancer, study finds

by BloodwiseCredit: Wikimedia CommonsSurvival times for a highly aggressive type of blood cancer have nearly doubled over the last decade due to the introduction of new targeted drugs, a Yorkshire stu

Updated on: March 12,2024

New drugs are improving survival times for patients with aggressive type of blood cancer, study finds

by BloodwiseCredit: Wikimedia CommonsSurvival times for a highly aggressive type of blood cancer have nearly doubled over the last decade due to the introduction of new targeted drugs, a Yorkshire stu

Updated on:March 12,2024

How Leukemia Is Treated

How Leukemia Is TreatedByKaren RaymaakersUpdated on January 22, 2023Medically reviewed byDouglas A. Nelson, MDThe treatment forleukemiadepends on many factors inclu

Updated on: February 04,2024

How Leukemia Is Treated

How Leukemia Is TreatedByKaren RaymaakersUpdated on January 22, 2023Medically reviewed byDouglas A. Nelson, MDThe treatment forleukemiadepends on many factors inclu

Updated on:February 04,2024

Aging and cancer hallmarks as therapeutic targets

by Compuscript LtdCrosstalk between aging and cancer hallmarks. (a) Aging hallmarks are categorized into five groups based on correlation with cancer hallmarks. (b) Hallmarks shared between aging and

Updated on: January 04,2024

Aging and cancer hallmarks as therapeutic targets

by Compuscript LtdCrosstalk between aging and cancer hallmarks. (a) Aging hallmarks are categorized into five groups based on correlation with cancer hallmarks. (b) Hallmarks shared between aging and

Updated on:January 04,2024

BCMA+ EV levels correlate with myeloma response to belantamab-mafodotin

by Impact Journals LLCPatient examples of inverse correlation of BCMA and FLC changes during course of therapy. Credit: 2023 Springer et al.A new research paper was published inOncotarget, entit

Updated on: January 26,2024

BCMA+ EV levels correlate with myeloma response to belantamab-mafodotin

by Impact Journals LLCPatient examples of inverse correlation of BCMA and FLC changes during course of therapy. Credit: 2023 Springer et al.A new research paper was published inOncotarget, entit

Updated on:January 26,2024

Two mutations team up to cloak a deadly brain cancer from the immune system, study suggests

by UF HealthGraphical Abstract. Credit:Cell Reports(2023). DOI: 10.1016/j.celrep.2023.112235A new study of the aggressive brain cancer glioblastoma suggests that two specific cancer cell m

Updated on: January 22,2024

Two mutations team up to cloak a deadly brain cancer from the immune system, study suggests

by UF HealthGraphical Abstract. Credit:Cell Reports(2023). DOI: 10.1016/j.celrep.2023.112235A new study of the aggressive brain cancer glioblastoma suggests that two specific cancer cell m

Updated on:January 22,2024

Medical scientists describe optimal immune therapeutic strategies for liver cancer

by The Korea Advanced Institute of Science and Technology (KAIST)Schematic image of study. Credit: KAISTKAIST medical scientists have presented a novel pathways involving T immune cell exhaustion

Updated on: May 13,2024

Medical scientists describe optimal immune therapeutic strategies for liver cancer

by The Korea Advanced Institute of Science and Technology (KAIST)Schematic image of study. Credit: KAISTKAIST medical scientists have presented a novel pathways involving T immune cell exhaustion

Updated on:May 13,2024

Research concentrates on genes that cause tumors in the Meibomian gland

byTufts UniversityDr. Cornelia Peterson calibrates a piece of equipment used to measure intraocular pressure during an ocular toxicity study in animals. Credit: Noah MossDr. Cornelia Peterson is

Updated on: December 01,2024

Research concentrates on genes that cause tumors in the Meibomian gland

byTufts UniversityDr. Cornelia Peterson calibrates a piece of equipment used to measure intraocular pressure during an ocular toxicity study in animals. Credit: Noah MossDr. Cornelia Peterson is

Updated on:December 01,2024

Study finds a possible explanation for why immunotherapy works well for some cancer patients, but not others

by Yale UniversityCredit:Cancer Discovery(2022). DOI: 10.1158/2159-8290.CD-22-0686Immunotherapy, a biotherapy that boosts the ability of the immune system to recognize and attack muta

Updated on: January 30,2024

Study finds a possible explanation for why immunotherapy works well for some cancer patients, but not others

by Yale UniversityCredit:Cancer Discovery(2022). DOI: 10.1158/2159-8290.CD-22-0686Immunotherapy, a biotherapy that boosts the ability of the immune system to recognize and attack muta

Updated on:January 30,2024

Researchers develop 'Goldilocks drug' to treat triple-negative breast cancer

by Mikayla Mace Kelley,University of ArizonacSNX1.3 competitively inhibits binding of EGFR to SNX1.ARibbon drawing of EGFR kinase domain (PDB ID 5CNO) and SNX1 Bar domain (PDB ID 4FZ

Updated on: February 20,2024

Researchers develop 'Goldilocks drug' to treat triple-negative breast cancer

by Mikayla Mace Kelley,University of ArizonacSNX1.3 competitively inhibits binding of EGFR to SNX1.ARibbon drawing of EGFR kinase domain (PDB ID 5CNO) and SNX1 Bar domain (PDB ID 4FZ

Updated on:February 20,2024